Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Shafran

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patientsStephen D Shafran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV TrialsStephen D Shafran
Canadian Journal of Gastroenterology & Hepatology|February 24, 2015
The hepatitis C genotype 1 paradox: cost per treatment is increasing, but cost per cure is decreasingStephen D Shafran
The Annals of Pharmacotherapy|March 2, 2006
Treatment of hepatitis C in HIV-coinfected patientsChristine A Hughes, Stephen D Shafran
The Annals of Pharmacotherapy|December 22, 2005
Chronic hepatitis C virus management: 2000-2005 updateChristine A Hughes, Stephen D Shafran
HIV Medicine|August 16, 2022
Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistanceStephen D Shafran, Christine A Hughes
The Journal of Infection|September 1, 2004
The effect of current management on morbidity and mortality in hospitalised adults with funguriaChristine Simpson, Sandra Blitz, Stephen D Shafran
The Annals of Pharmacotherapy|November 26, 2009
Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavirCara Hills-Nieminen, Christine A Hughes, Stan Houston, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 8, 2021
Hepatitis C direct-acting antiviral outcomes in patients 75 years and olderParmvir Parmar, Stephen D Shafran, Sergio M Borgia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trialStephen L Sacks, Fred Y Aoki, Alain Y Martel, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patientsStephen D Shafran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV TrialsStephen D Shafran
Canadian Journal of Gastroenterology & Hepatology|February 24, 2015
The hepatitis C genotype 1 paradox: cost per treatment is increasing, but cost per cure is decreasingStephen D Shafran
The Annals of Pharmacotherapy|March 2, 2006
Treatment of hepatitis C in HIV-coinfected patientsChristine A Hughes, Stephen D Shafran
The Annals of Pharmacotherapy|December 22, 2005
Chronic hepatitis C virus management: 2000-2005 updateChristine A Hughes, Stephen D Shafran
HIV Medicine|August 16, 2022
Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistanceStephen D Shafran, Christine A Hughes
The Journal of Infection|September 1, 2004
The effect of current management on morbidity and mortality in hospitalised adults with funguriaChristine Simpson, Sandra Blitz, Stephen D Shafran
The Annals of Pharmacotherapy|November 26, 2009
Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavirCara Hills-Nieminen, Christine A Hughes, Stan Houston, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 8, 2021
Hepatitis C direct-acting antiviral outcomes in patients 75 years and olderParmvir Parmar, Stephen D Shafran, Sergio M Borgia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trialStephen L Sacks, Fred Y Aoki, Alain Y Martel, et al.
Pageof 4